Clinical Trial Update: Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

An extension-phase 2 trial evaluated the efficacy and safety of repeat Rituximab treatment in adults with active rheumatoid arthritis. The study has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (MabThera) (Rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2017-03-13